Both in Pharmaceuticals
Avalo Therapeutics vs Lexicon Pharmaceuticals
Over the past year AVTX returned +19.7% and LXRX returned +35.3%; their daily moves had a correlation of 0.25.
AVTX +19.7% LXRX +35.3%Growth of $1, one year, split-adjusted
| Metric | AVTX | LXRX |
|---|---|---|
| Price | $15.58 | $1.88 |
| Market cap | $835.6M | $836.5M |
| Today | +3.32% | −1.05% |
| 1 month | −20.5% | −17.9% |
| 6 months | +11.8% | +24.5% |
| Year to date | −14.2% | +63.5% |
| 1 year | +44.3% | +34.3% |
| Revenue growth (YoY) | — | −97.6% |
| Gross margin | — | 94.4% |
| Net margin | — | −4591.8% |
| P/E (TTM) | — | — |
| Price / sales | 14,162.0× | 20.2× |
| Net cash | $400.3M | $139.2M |
| Dividend yield | — | — |
| Volatility (60d) | 54.8% | 55.0% |
| Short % of float | 24.9% | 12.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).